Materialise (Nasdaq: MTLS) expands from Belgium to the US, establishing a new 3D printing facility in Michigan. This move aims to provide American doctors with titanium cranio-maxillofacial implants more efficiently. Alongside current US-based production of surgical guides and anatomical models, this expansion enhances personalized medical care across the nation. The significance of 3D printing in tailored patient care is growing. The medical 3D printing market is projected to reach $6.08 billion by 2027, driven by its potential to improve surgical precision and save time. A study found that 3D-printed anatomical models could reduce surgery time by an average of 62 minutes, leading to lower patient risk and cost savings of over $3,700 per case. Read the full article here: 3dprint.com/...